These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8751558)

  • 21. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB; Iversen OE; Akslen LA
    Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian preservation in stage I low-grade endometrial stromal sarcomas.
    Li AJ; Giuntoli RL; Drake R; Byun SY; Rojas F; Barbuto D; Klipfel N; Edmonds P; Miller DS; Karlan BY
    Obstet Gynecol; 2005 Dec; 106(6):1304-8. PubMed ID: 16319256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical stage I and II endometrial carcinoma: multivariate analysis of prognostic factors.
    Mammoliti S; Bruzzone M; Chiara S; Vidali A; Miglio L; Fontana V; Oliva C; Compora E; Giuntini P; Centonze M
    Anticancer Res; 1992; 12(5):1415-8. PubMed ID: 1444199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial stromal sarcoma: a population-based analysis.
    Chan JK; Kawar NM; Shin JY; Osann K; Chen LM; Powell CB; Kapp DS
    Br J Cancer; 2008 Oct; 99(8):1210-5. PubMed ID: 18813312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma.
    Shah JP; Bryant CS; Kumar S; Ali-Fehmi R; Malone JM; Morris RT
    Obstet Gynecol; 2008 Nov; 112(5):1102-8. PubMed ID: 18978112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrial stromal sarcoma: analysis of treatment failures and survival.
    Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Urgesi A; Lissoni A; Losa G; Fanucchi A
    Gynecol Oncol; 1996 Nov; 63(2):247-53. PubMed ID: 8910635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.
    Bergers E; Baak JP; van Diest PJ; Willig AJ; Los J; Peterse JL; Ruitenberg HM; Schapers RF; Somsen JG; van Beek MW; Bellot SM; Fijnheer J; van Gorp LH
    Mod Pathol; 1997 Aug; 10(8):762-8. PubMed ID: 9267817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.
    Santoro E; Carboni M; Catarci M; Carlini M; Carboni F; Zupi G; Vecchione A; D'Agnano I; Giannarelli D; Santoro R; Garofalo A
    Hepatogastroenterology; 1997; 44(15):826-37. PubMed ID: 9222700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations.
    Semczuk A; Lorenc A; Putowski L; Futyma K; Bryk J; Miotla P; Bartnik E
    Oncol Rep; 2006 Nov; 16(5):1041-5. PubMed ID: 17016590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA ploidy as a prognostic factor for patients with an adenocarcinoma in Barrett's esophagus.
    Menke-Pluymers MB; Hop WC; Mulder AH; Tilanus HW
    Hepatogastroenterology; 1995; 42(6):786-8. PubMed ID: 8847023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma.
    Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor cell cycle in patients with stage I endometrial carcinoma.
    Vecek N; Nola M; Marusić M; Babić D; Uzarević B; Sabioncello A; Petrovecki M; Ljubić-Racunica N; Marinović T
    Gynecol Oncol; 1994 Apr; 53(1):38-43. PubMed ID: 8175020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
    Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
    Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence in situ hybridization and immunohistochemical analysis of p53 expression in endometrial cancer: prognostic value and relation to ploidy.
    Graesslin O; Chantot-Bastaraud S; Lorenzato M; Birembaut P; Quéreux C; Daraï E
    Ann Surg Oncol; 2008 Feb; 15(2):484-92. PubMed ID: 18071824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of DNA ploidy in breast cancer stage I-II.
    Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
    Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma.
    Bell JG; Minnick A; Reid GC; Judis J; Brownell M
    Gynecol Oncol; 1997 Sep; 66(3):388-92. PubMed ID: 9299250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.